Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 6/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | IKBKB | O14920 | 1/20 | 0.34 |
| ▸ | PARP10 | Q53GL7 | 3/20 | 0.33 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | EDNRA | P25101 | 1/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30656034 | 0.90 | SLC26A4 (0.33) | ROCK2L3MBTL1PARP10PARP15BACE1 | |
| SCHEMBL30655957 | 0.87 | CD38 (0.38) | ROCK2L3MBTL1EDNRATDP1KDM4E | |
| SCHEMBL31350375 | 0.86 | ICAM1 (0.41) | SLC13A5ROCK2L3MBTL1IKBKBPARP10 | |
| SCHEMBL30656180 | 0.84 | HPGDS (0.37) | L3MBTL1HDAC6IKBKBEDNRA | |
| SCHEMBL30656124 | 0.84 | HPGDS (0.37) | L3MBTL1HDAC6IKBKBEDNRA | |
| SCHEMBL26792937 | 0.84 | PARP10 (0.45) | PARP10PARP15PARP14 | |
| SCHEMBL30656221 | 0.84 | PARP10 (0.43) | PARP10 | |
| SCHEMBL30655951 | 0.84 | EDNRA (0.47) | L3MBTL1PARP10EDNRAKDM4EMAPT | |
| SCHEMBL30656105 | 0.83 | CD274 (0.34) | ROCK2L3MBTL1HDAC6IKBKBPARP10 | |
| SCHEMBL26793645 | 0.83 | CD274 (0.34) | ROCK2L3MBTL1HDAC6IKBKBPARP10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | claimed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | claimed |
| EP-4532013-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | Katholieke Universiteit Leuven KU Leuven Research & Development (BE) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023227697-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | disclosed |